Pharmaceutical Companies
Vaxart
🇺🇸United States
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines...
XBiotech
🇺🇸United States
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The...
Inovio Pharmaceuticals
🇺🇸United States
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100,...
Mersana Therapeutics
🇺🇸United States
Innate Pharma, Inc.
🇺🇸United States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $191M
- Website
- -
Race Oncology
🇧🇪Belgium
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $190.9M
- Website
- -
SKYE BIOSCIENCE INC
🇺🇸United States
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders,...
Context Therapeutics
🇺🇸United States
- Ownership
- -
- Established
- -
- Employees
- 5
- Market Cap
- $187.4M
- Website
- -
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform...
MediWound
🇮🇱Israel
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product...
Greenwich LifeSciences
🇺🇸United States
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 7
- Market Cap
- $183.8M
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered...